Serologic response in patients with paroxysmal nocturnal hemoglobinuria (PNH) after vaccination against meningococci for the chronic treatment with the terminal complement inhibitor eculizumab: A retrospective analysis

被引：0
|
作者：
Alashkar, F. [1 ]
Herich-Terhuerne, D. [1 ]
Duehrsen, U. [1 ]
Roeth, A. [1 ]
机构：
[1] Univ Klinikum Essen, Westdeutsch Tumorzentrum, Klin Hamatol, Essen, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2014年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V755
引用
收藏
页码：245 / 246
页数：2
相关论文
共 50 条
  • [1] Serologic Response to Meningococcal Vaccination in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) for the Chronic Treatment with the Terminal Complement Inhibitor Eculizumab
    Roeth, Alexander
    Alashkar, Ferras
    Herich-Terhuerne, Doerte
    Elias, Johannes
    Vogel, Ulrich
    Duehrsen, Ulrich
    [J]. BLOOD, 2014, 124 (21)
  • [2] Serologic response to meningococcal vaccination in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with the terminal complement inhibitor eculizumab
    Ferras Alashkar
    Colin Vance
    Dörte Herich-Terhürne
    Nicole Preising
    Ulrich Dührsen
    Alexander Röth
    [J]. Annals of Hematology, 2017, 96 : 589 - 596
  • [3] Serologic response to meningococcal vaccination in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with the terminal complement inhibitor eculizumab
    Alashkar, Ferras
    Vance, Colin
    Herich-Terhuerne, Doerte
    Preising, Nicole
    Duehrsen, Ulrich
    Roeth, Alexander
    [J]. ANNALS OF HEMATOLOGY, 2017, 96 (04) : 589 - 596
  • [4] Terminal complement inhibitor eculizumab improves complement-mediated platelet consumption and thrombocytopenia in patients with paroxysmal nocturnal hemoglobinuria (PNH)
    Hill, A.
    Socie, G.
    Muus, P.
    Schrezenmeier, H.
    Hochsmann, B.
    Maciejewski, J.
    Weitz, I. C.
    Bessler, M.
    Risitano, A. M.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2010, 149 : 10 - 10
  • [5] Terminal Complement Inhibitor Eculizumab Improves Complement-Mediated Platelet Consumption and Thrombocytopenia in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)
    Socie, Gerard
    Muus, Petra
    Schrezenmeier, Hubert
    Hoechsmann, Britta
    Maciejewski, Jaroslaw P.
    Weitz, Ilene Ceil
    Hill, Anita
    Bessler, Monica
    Risitano, Antonio M.
    [J]. BLOOD, 2009, 114 (22) : 1546 - 1547
  • [6] The complement inhibitor eculizumab improves anemia and reduces thrombosis in paroxysmal nocturnal hemoglobinuria (PNH) patients
    Risitano, A. M.
    Hillmen, P.
    Young, N. S.
    Muus, P.
    Duehrsen, U.
    Schubert, J.
    Schrezenmeier, H.
    Szer, J.
    Brodsky, R. A.
    Hill, A.
    Socie, G.
    Maciejewski, J. P.
    Rollins, S. A.
    Rother, R. P.
    Bell, L.
    Marinelli, F.
    Antonioli, E.
    Lori, A. P.
    Rodeghiero, F.
    Zanella, A.
    Luzzatto, L.
    Rotoli, B.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 88 - 88
  • [7] The terminal complement inhibitor eculizumab reduces thrombosis in patients with paroxysmal nocturnal hemoglobinuria.
    Hillmen, Peter
    Muus, Petra
    Duehrsen, Ulrich
    Risitano, Antonio M.
    Schubert, Joerg
    Young, Neal S.
    Schrezenmeier, Hubert
    Szer, Jeffrey
    Brodsky, Robert A.
    Hill, Anita
    Socie, Gerard
    Rollins, Scott A.
    Rother, Russell P.
    Bell, Leonard
    Luzzatto, Lucio
    [J]. BLOOD, 2006, 108 (11) : 40A - 41A
  • [8] Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria
    Rother, Russell P.
    Rollins, Scott A.
    Mojcik, Christopher F.
    Brodsky, Robert A.
    Bell, Leonard
    [J]. NATURE BIOTECHNOLOGY, 2007, 25 (11) : 1256 - 1264
  • [9] Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria
    Russell P Rother
    Scott A Rollins
    Christopher F Mojcik
    Robert A Brodsky
    Leonard Bell
    [J]. Nature Biotechnology, 2007, 25 : 1256 - 1264
  • [10] Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria
    Hillmen, Peter
    Muus, Petra
    Duhrsen, Ulrich
    Risitano, Antonio M.
    Schubert, Jorg
    Luzzatto, Lucio
    Schrezenmeier, Hubert
    Szer, Jeffrey
    Brodsky, Robert A.
    Hill, Anita
    Socie, Gerard
    Bessler, Monica
    Rollins, Scott A.
    Bell, Leonard
    Rother, Russell P.
    Young, Neal S.
    [J]. BLOOD, 2007, 110 (12) : 4123 - 4128
12345